The June quarter defined the year for International Flavors & Fragrances. Management finally announced the divestiture of the legacy Food Ingredients disposal group, a diversified specialty-food-ingredients business IFF inherited in large part through the 2021 Frutarom acquisition, in a transaction with CVC Capital Partners worth an estimated $3.8 billion in proceeds. Together with the completed divestiture of the Soy Crush, Concentrates and Lecithin businesses earlier in the year and the prior exit from Pharma Solutions, this is the moment the multi-year reshaping of the company formally converges on a three-segment "taste, scent and nutrition" platform. The disposals also allow management to retire a meaningful slice of senior debt, return cash to shareholders via the new $2.5 billion repurchase authorization, and shift attention back to operating the higher-margin businesses that remain.
The underlying second-quarter print supports that thesis more than the headline earnings suggest. Reported sales advanced 2% to $1.954 billion. Comparable currency-neutral revenue was up 6%. That reflects genuine volume and price progress across all three continuing segments. Adjusted operating EBITDA margin reached 20.9% for the continuing portfolio. That compares with 20.8% a year ago. The half-year view is more informative. Adjusted operating EBITDA from continuing operations reached $841 million. Operating margin expanded 250 basis points to 10.6%. Across the segments, the breadth of growth is the analytical point. In past quarters a single segment carried the consolidated comparable number while the others lagged. This quarter, all three delivered. The Food & Beverage-led Taste held steady while Scent led and Health & Biosciences followed. That consistency across customer-end-markets suggests the underlying volume story is not a one-segment phenomenon. It also reduces the dependence on any single buyer end-market for the next phase of comparable growth.
The quarter also delivered a structural resolution on the leverage question. Net debt at quarter-end stood at $5.166 billion. The net debt to credit-adjusted EBITDA ratio was 2.51x. That is comfortably inside the 3.75x covenant ceiling and well below the peak levels the franchise carried right after Frutarom closed. The equity has been changing hands near $85.78. The fifty-two-week range is $59.14 to $89.32. Market capitalization sits near $21.9 billion. The stock is no longer pricing in either the integration risk or the deleveraging optionality that defined the post-2021 narrative. The interpretive question is whether a meaningfully smaller, more focused IFF can compound at a level that justifies the current multiple given the muted organic growth profile. Investors should treat the recent move in the share price as a partial reflection of that narrative and not a foregone conclusion. The risk-reward is also more two-sided than it appears at first glance.